Related references
Note: Only part of the references are listed.Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis
Jiangfeng Wang et al.
ONCOTARGETS AND THERAPY (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Downregulation of microRNA-100/microRNA-125b is associated with lymph node metastasis in early colorectal cancer with submucosal invasion
Yasuteru Fujino et al.
CANCER SCIENCE (2017)
Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017
Aimee L. Lucas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
Andrea Wang-Gillam et al.
LANCET (2016)
Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential
Chen Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis
Adam E. Frampton et al.
EUROPEAN JOURNAL OF CANCER (2015)
MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II
Sameer Abdallah Dhayat et al.
CLINICAL EPIGENETICS (2015)
MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
Sameer A. Dhayat et al.
PLOS ONE (2015)
MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis
Wenjia Wang et al.
BMC CANCER (2014)
Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells
D. Sun et al.
ONCOGENE (2014)
Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
Ramadevi Subramani et al.
PLOS ONE (2014)
A miRNA Signature of Chemoresistant Mesenchymal Phenotype Identifies Novel Molecular Targets Associated with Advanced Pancreatic Cancer
Alakesh Bera et al.
PLOS ONE (2014)
MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R
Yi-Yuan Ge et al.
ONCOTARGET (2014)
MicroRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells
J. S. Huang et al.
BIOTECHNIC & HISTOCHEMISTRY (2013)
MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways
X-J Li et al.
BRITISH JOURNAL OF CANCER (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
MicroRNA Expression Aids the Preoperative Diagnosis of Pancreatic Ductal Adenocarcinoma
Nicole C. Panarelli et al.
PANCREAS (2012)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Tissue and Serum microRNAs in the KrasG12D Transgenic Animal Model and in Patients with Pancreatic Cancer
Joseph J. LaConti et al.
PLOS ONE (2011)
MiRNA Expression in Psoriatic Skin: Reciprocal Regulation of hsa-miR-99a and IGF-1R
Galya Lerman et al.
PLOS ONE (2011)
MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
Elisa Giovannetti et al.
CANCER RESEARCH (2010)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
